CD1-lipid reactivity of epidermal T cells
表皮 T 细胞的 CD1-脂质反应性
基本信息
- 批准号:8809549
- 负责人:
- 金额:$ 25.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-08 至 2017-01-31
- 项目状态:已结题
- 来源:
- 关键词:AntigensAutoimmune DiseasesBindingBloodCellsCeramidesCharacteristicsChronicCloningComplexDataDermalDiseaseEpidermisFutureGenerationsHealedHumanIndividualInflammationInflammatoryIntestinesLangerhans cellLipid BindingLipidsMicrobeMusOilsPopulationProteinsReportingSebaceous GlandsSebumSeriesSignal TransductionSkinSkin NeoplasmsSourceSqualeneStressSulfoglycosphingolipidsT-LymphocyteTestingWound Healinghealingimprovedkeratinocyteperipheral bloodpublic health relevanceresponse
项目摘要
DESCRIPTION (provided by applicant): Since the initial discovery of ?� cells 30 years ago, non-classical MHC molecules have been proposed as antigens or antigen presenting molecules for these cells. In the intervening years, individual T cell clones have been identified with reactivity to CD1 and TL molecules but MHC reactivity has not been shown for populations of ?� cells. Recent data from two groups has now shown that the V?1+ TCR from human peripheral blood and intestinal ?� cells can directly bind to CD1d-?GalCer and CD1d-sulfatide. Interestingly, the V?1+ TCR is also used by epidermal-resident ?� cells in both human and mouse skin. CD1 expression is upregulated on epidermal cells during skin inflammation and disease and the epidermis is a rich source of lipids and skin oils. This raises the possibility tha CD1-lipid reactivity may be characteristic of all V?1+ T cells, including those that are resident i the epidermis. We propose to test the hypothesis that CD1-skin lipid antigens can provide a stress-signal of damage or disease in the epidermis to neighboring V?1+ T cells to activate their wound healing functions. We will test this hypothesis by determining if the human or mouse V?1+ TCR can interact with CD1-lipid antigens and by investigating whether CD1d expression during wound healing impacts epidermal ?� cell wound healing responses. If found to be a prototypic stress-signal for ?� cell activation, CD1 or skin lipids may then be considered as targets in future strategies to improve healing of chronic wounds as well as other skin inflammatory or autoimmune diseases.
描述(由申请人提供):自最初发现?30年前,非经典MHC分子被提出作为这些细胞的抗原或抗原提呈分子。在这期间的几年里,个体T细胞克隆已被鉴定出对CD1和TL分子具有反应性,但MHC反应性尚未显示在?�细胞。最近来自两个小组的数据显示,V?1+ TCR来自人外周血和肠道?细胞可以直接结合CD1d-?GalCer和cd1 -硫脂。有趣的是,V?1+ TCR也用于表皮驻留?人类和老鼠皮肤中的细胞。在皮肤炎症和疾病期间,CD1在表皮细胞上的表达上调,而表皮是脂质和皮肤油脂的丰富来源。这提出了一种可能性,即cd1 -脂质反应性可能是所有V?1+ T细胞,包括居住在表皮的细胞。我们提议验证这样一种假设,即cd1皮肤脂质抗原可以向邻近的表皮细胞提供损伤或疾病的应激信号。激活1+ T细胞的伤口愈合功能。我们将通过确定人类或小鼠V?1+ TCR可以与cd1脂质抗原相互作用,并通过研究伤口愈合过程中CD1d的表达是否影响表皮?-细胞伤口愈合反应。如果被发现是一个典型的压力信号?细胞活化、CD1或皮肤脂质可能被认为是未来改善慢性伤口愈合以及其他皮肤炎症或自身免疫性疾病策略的目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wendy L. Havran其他文献
Oiling the wheels of autoimmunity
给自身免疫的车轮上油
- DOI:
10.1038/506042a - 发表时间:
2014-02-05 - 期刊:
- 影响因子:48.500
- 作者:
Mitchell Kronenberg;Wendy L. Havran - 通讯作者:
Wendy L. Havran
The Biology of <em>γδ</em> T Cells: What Is the Relationship between <em>γδ</em> T Cells and Cancer? Will an Increased Number and/or Function of <em>γδ</em> T Cells Result in Lower Cancer Incidence?
- DOI:
10.1093/jn/135.12.2909s - 发表时间:
2005-12-01 - 期刊:
- 影响因子:
- 作者:
Wendy L. Havran - 通讯作者:
Wendy L. Havran
γδ T cells and IgE team up to prevent tumors
γδ T 细胞和免疫球蛋白 E 联手预防肿瘤
- DOI:
10.1038/s41590-018-0167-2 - 发表时间:
2018-07-16 - 期刊:
- 影响因子:27.600
- 作者:
J. Michael McGraw;Wendy L. Havran - 通讯作者:
Wendy L. Havran
Wendy L. Havran的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wendy L. Havran', 18)}}的其他基金
Expression of gamma delta TCR ligands in development
发育中γδTCR配体的表达
- 批准号:
9332915 - 财政年份:2017
- 资助金额:
$ 25.01万 - 项目类别:
Mechanism-Based Wound Healing by Activation of gamma delta T Cells
通过激活 γ δ T 细胞实现基于机制的伤口愈合
- 批准号:
9104102 - 财政年份:2015
- 资助金额:
$ 25.01万 - 项目类别:
Mechanism-Based Wound Healing by Activation of gamma delta T Cells
通过激活 γ δ T 细胞实现基于机制的伤口愈合
- 批准号:
8954537 - 财政年份:2015
- 资助金额:
$ 25.01万 - 项目类别:
Role of EPCR in gamma delta T cell wound healing functions
EPCR 在 γδT 细胞伤口愈合功能中的作用
- 批准号:
8571495 - 财政年份:2013
- 资助金额:
$ 25.01万 - 项目类别:
Role of EPCR in gamma delta T cell wound healing functions
EPCR 在 γδT 细胞伤口愈合功能中的作用
- 批准号:
8672596 - 财政年份:2013
- 资助金额:
$ 25.01万 - 项目类别:
Identification of skin gamma delta T cell antigens
皮肤 γ δ T 细胞抗原的鉴定
- 批准号:
8269042 - 财政年份:2011
- 资助金额:
$ 25.01万 - 项目类别:
Identification of skin gamma delta T cell antigens
皮肤 γ δ T 细胞抗原的鉴定
- 批准号:
8177647 - 财政年份:2011
- 资助金额:
$ 25.01万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 25.01万 - 项目类别:
Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 25.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 25.01万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 25.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 25.01万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 25.01万 - 项目类别:
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 25.01万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 25.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 25.01万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 25.01万 - 项目类别: